<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Miyoshi <z:hpo ids='HP_0003198'>myopathy</z:hpo> (MM) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> distal <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> characterized by mutations of the dysferlin gene </plain></SENT>
<SENT sid="1" pm="."><plain>Although several pairs of homozygous/heterozygous mutations have been reported, few effective treatments of MM are available </plain></SENT>
<SENT sid="2" pm="."><plain>We had observed the decreased serum <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (CK) before and after administration of dantrolene in the elder brother and the <z:hpo ids='HP_0003236'>increased serum CK</z:hpo> before and after discontinuance of the drug on suspicion of drug-induced <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatopathy</z:e> in the younger sister </plain></SENT>
<SENT sid="3" pm="."><plain>We report a novel pair of heterozygous mutations in the 3'-splicing site of exon 26 and the translation site of exon 28 of the dysferlin gene in two siblings, and effective treatment of their MM with dantrolene </plain></SENT>
</text></document>